Ticker Scorecard - EOLS Basics Company: Evolus, Inc. IPO Date: February 5, 2018 Sector: Healthcare Industry: Drug Manufacturers Market Cap: $885.87M Activated in VL: True Average Daily Range Avg Daily Range: $0.38 | 3.20% Avg Daily Range (30 D): $0.38 | 2.92% Avg Daily Range (90 D): $0.33 | 2.47% Institutional Daily Volume Avg Daily Volume: .56M Avg Daily Volume (30 D): .78M Avg Daily Volume (90 D): .61M Trade Size Avg Trade Size (Sh.): 114 Avg Trade Size (Sh.) (30 D): 71 Avg Trade Size (Sh.) (90 D): 70 Institutional Trades Total Inst.Trades: 797 Avg Inst. Trade: $1.47M Avg Inst. Trade (30 D): $1.04M Avg Inst. Trade (90 D): $1.14M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.19M Avg Closing Trade (30 D): $.98M Avg Closing Trade (90 D): $.97M Avg Closing Volume: 91.33K     News Jun 6, 2024 @ 12:00 PM Rare Stock Picks In May 2024 - From 29 Discerning ... Source: SA Rare Stock Picks Monthly May 21, 2024 @ 2:57 PM Evolus (EOLS) Releases Favorable Dermal Fillers St... Source: Zacks Equity Research May 7, 2024 @ 10:35 PM Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue ... Source: Zacks Equity Research May 3, 2024 @ 11:25 AM 4 Stocks to Keep a Tab on for Amazing Earnings Acc... Source: Tirthankar Chakraborty May 1, 2024 @ 6:29 AM Green Thumb Industries Inc. (GTBIF) Surges 22.3%: ... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.91 $-.3 $-.18 Diluted EPS $-.91 $-.3 $-.18 Revenue $ 248.33M $ 61.09M $ 66.91M Gross Profit $ 173.69M $ 42.86M $ 47.83M Net Income / Loss $ -55.46M $ -19.17M $ -11.35M Operating Income / Loss $ -40.73M $ -15.47M $ -7.7M Cost of Revenue $ 74.64M $ 18.22M $ 19.08M Net Cash Flow $ 46.35M $ -8.64M $ -3.29M PE Ratio